Addus HomeCare (NASDAQ:ADUS) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Key Points

• Addus HomeCare reported quarterly EPS of $1.83, beating the $1.79 consensus estimate by $0.04.
• Quarterly revenue was $387.74 million, slightly below analysts’ $388.72 million estimate.
• Shares rose 0.6% to $126.55, while analysts’ consensus rating was Moderate Buy with a $129.33 price target.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported $1.83 EPS for the quarter, topping the consensus estimate of $1.79 by $0.04, FiscalAI reports. The company had revenue of $387.74 million during the quarter, compared to analyst estimates of $388.72 million. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.

Addus HomeCare Stock Up 0.6%

Shares of ADUS stock traded up $0.80 during mid-day trading on Tuesday, reaching $126.55. 453,570 shares of the company's stock traded hands, compared to its average volume of 235,769. The company's 50-day moving average price is $117.10 and its 200-day moving average price is $106.54. The company has a market cap of $2.36 billion, a P/E ratio of 22.20, a P/E/G ratio of 1.74 and a beta of 0.83. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.05. Addus HomeCare has a 12 month low of $87.95 and a 12 month high of $127.08.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the stock. Citigroup lowered shares of Addus HomeCare from a "market outperform" rating to a "neutral" rating in a report on Monday, September 14th. Barclays upped their price target on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an "underweight" rating in a research report on Wednesday, July 8th. Bank of America cut Addus HomeCare from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $140.00 to $125.00 in a research note on Monday, September 14th. Weiss Ratings upgraded Addus HomeCare from a "hold (c)" rating to a "hold (c+)" rating in a report on Thursday, September 24th. Finally, Royal Bank Of Canada boosted their target price on Addus HomeCare from $130.00 to $134.00 and gave the company an "outperform" rating in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $129.33.

Addus HomeCare Company Profile

Addus HomeCare Inc NASDAQ: ADUS provides in-home personal care, hospice and home health services to older adults, people with disabilities and other individuals who need assistance with daily living or medical care. Its services are designed to help clients remain safely and independently in their homes while supporting families and caregivers.

The company's personal care services include assistance with bathing, dressing, grooming, meal preparation, housekeeping and other activities of daily living.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.